LAG-3 and PD-1+LAG-3 inhibition promote anti-tumor immune responses in human autologous melanoma/T cell co-cultures

Despite the success of immunotherapy using checkpoint blockade, many patients with solid tumors remain refractory to these treatments. In human cancer, the experimental options to investigate the specific effects of antibodies blocking inhibitory receptors are limited and it is still unclear which c...

Descripción completa

Detalles Bibliográficos
Autores principales: Gestermann, Nicolas, Saugy, Damien, Martignier, Christophe, Tillé, Laure, Fuertes Marraco, Silvia A., Zettl, Markus, Tirapu, Iñigo, Speiser, Daniel E., Verdeil, Grégory
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7422827/
https://www.ncbi.nlm.nih.gov/pubmed/32850194
http://dx.doi.org/10.1080/2162402X.2020.1736792

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7422827/
https://www.ncbi.nlm.nih.gov/pubmed/32850194
http://dx.doi.org/10.1080/2162402X.2020.1736792

Ejemplares similares